Skip to main content

Clinical Trial News

This section provides information about recently completed clinical trials. If you cannot find information about a particular clinical trial, you should note that results may not be available even after the trial ends. Some trials end before completion and results are never published.

MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal

NEW YORK, May 19, 2022,. Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company...

Pre-clinical findings support the potential use of RhoVac's drug candidate, onilcamotide, across several cancers

STOCKHOLM, May 18, 2022 , RhoVac AB ("RHOVAC") today, 18th May 2022, announces preclinical findings from its collaboration with St. John's Research Institute...

Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age

NEW YORK & MAINZ, Germany, May 17, 2022 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration...

First patient randomized in Phase 2 trial in head and neck cancer

STOCKHOLM, May 17, 2022.Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the first patient has been...

PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab

MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--May 16, 2022-- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused...

Scientists Identify Characteristics to Better Define Long COVID

May 16, 2022 -- A research team supported by the National Institutes of Health has identified characteristics of people with long COVID and those likely to...

FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 16, 2022-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) has...

Diadem Announces Publication of Clinical Study Confirming Its AlzoSure Predict Blood Test Can Accurately Predict Progression to Alzheimer's Disease Six Years Before Diagnosis

MILAN, May 16, 2022. Diadem SpA today announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV)...

Galera Announces Plan to Submit Avasopasem NDA by Year End

After discussions with FDA, Company is on track to file an NDA for avasopasem for the treatment of radiotherapy-induced severe oral mucositis by end of...

Boehringer Ingelheim’s Latest Investigational Treatment BI 1015550 Slowed Lung Function Decline in People Living with Idiopathic Pulmonary Fibrosis

Promising 12-week Phase II trial data with BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, published in The New England...

PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide Used as Rescue Medicine Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients with Asthma

First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations MANDALA Phase III trial results...

New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis

POETYK PSO long-term extension trial results show maintenance of efficacy response through up to two years of treatment Results add to the growing body of...

Vaccine for Rare But Deadly Mosquito-Borne Viruses Shows Promise in Clinical Trial

May 12, 2022 -- A vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus...

NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar Depression with Sub-Acute Suicidality

RADNOR, Pa., May 12, 2022. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmaceutical company, today announced that...

Rinvoq Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn's Disease

NORTH CHICAGO, Ill., May 11, 2022. AbbVie today announced positive topline results from U-ENDURE, its Phase 3 maintenance study evaluating upadacitinib in...

Results from Trial on Sufentanil Sublingual Tablet Compared to Standard Intravenous Opioids during Plastic Surgery Procedures Performed under General Anesthesia

HAYWARD, Calif., May 10, 2022. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative...

Genentech Reports Interim Results for Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer

The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival The other co-primary...

Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Omicron BA.2 Subvariant

DURHAM, N.C. and BEIJING, May 9, 2022. Brii Biosciences Limited ("Brii Bio" or the "Company"), a multi-national company developing innovative therapies for...

NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine

May 6, 2022 -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage...

View older articles

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.